02/18/2026
A big thanks to NPR for featuring an article about a promising candidate for a preeclampsia therapeutic, in development by one of our corporate partners, DiaMedica Therapeutics. While the research is still in early testing, researchers believe the possibilities are promising:
"They were testing a drug for certain types of stroke called DM199 that functioned in a way they thought might also work for preeclampsia. [Dr. Catherine] Cluver was skeptical at first, but on closer inspection, she and her colleagues thought maybe it was worth trying out. "It could potentially work because it's ticking all the boxes of what we would want," she says.
So they began a trial at the hospital for mothers with dangerously high blood pressure and who were scheduled to deliver their babies early. When the 16th patient received the next highest dose, however, 'we literally just opened up this IV infusion and then her blood pressure stabilized,' recalls Cluver. 'We suddenly saw these sky-high blood pressures coming down and we were like, 'We don't believe this. This is impossible!'
'That's actually when the real excitement started,' says Thake. 'Like jumping up and down. I [sent] a gazillion emojis celebrating the blood pressure going down.' And it stayed down. The same was true for subsequent patients with the same or incrementally higher doses.
[. . .] Cluver and her colleagues are hopeful that this might be the first pharmaceutical treatment for preeclampsia."
Read more: https://www.npr.org/2026/02/14/nx-s1-5708744/preeclampsia-pregnancy-complication-treatment